Related Experiment Video
Updated: Aug 10, 2026

Murine Renal Transplantation Procedure
Published on: July 10, 2009
Cystatin C and creatinine after successful kidney transplantation in children
A Bökenkamp1, N Ozden, C Dieterich
1Children's Hospital, Hannover, Germany.
Insights
Cystatin C showed early promise as a marker for kidney transplant function in children. However, it was not more effective than creatinine in detecting acute allograft dysfunction.
Area of Science:
- Pediatric Nephrology
- Transplantation Immunology
- Biomarker Discovery
Background:
- Serum creatinine is a standard marker for renal transplant function but is less sensitive in children due to lower muscle mass.
- Cystatin C, a protein reflecting glomerular filtration rate, is independent of age and body composition, making it a potential alternative in pediatric patients.
- Assessing cystatin C's utility is crucial for accurate allograft monitoring in children post-renal transplantation.
Purpose of the Study:
- To evaluate cystatin C as a sensitive marker for monitoring kidney allograft function in pediatric patients after renal transplantation.
- To compare the performance of cystatin C with serum creatinine in detecting allograft dysfunction in children.
Main Methods:
- Cystatin C and creatinine levels were measured daily in 24 children following successful renal transplantation.
- Immunoturbidimetric and enzymatic methods were used for cystatin C and creatinine assays, respectively.
- Data were collected during hospitalization to assess early allograft function and detect dysfunction.
Main Results:
- Cystatin C levels decreased significantly within an hour post-transplantation, indicating early graft function.
- Both cystatin C and creatinine showed comparable day-to-day variations at steady-state.
- During acute rejection episodes, both markers increased, with creatinine showing a more pronounced rise.
Conclusions:
- Cystatin C serves as an early indicator of kidney allograft function after successful renal transplantation in children.
- Cystatin C did not demonstrate superiority over creatinine in identifying acute allograft dysfunction in this pediatric cohort.
- Further research may explore combined marker strategies for enhanced allograft monitoring.
Background:
Serum creatinine is commonly used for the monitoring of allograft function following renal transplantation (RTX). Due to lower muscle mass, creatinine production rate is reduced in children, thus decreasing its sensitivity for the detection of allograft dysfunction. In children, the serum concentration of cystatin C, a low molecular weight protein of 13.3 kDa, reflects glomerular filtration rate independent of age, height and body composition. We, therefore, sought to assess the potential of cystatin C as a marker of allograft function in children.
Methods:
Cystatin C and creatinine were measured in parallel at least daily in 24 children (14 boys, 10 girls; mean age 10.5+/-5.1 years) during hospitalization after successful RTX. Cystatin was determined immunoturbidimetrically, creatinine enzymatically.
Results:
Within one hour after RTX, cystatin C (mean+/-SE) almost halved from 6.69+/-0.45 mg/l to 3.69+/-0.38 mg/l while creatinine declined from 862 +/-65.4 to 633+/-62.9 micromol/l. Following a nadir of 1.82+/-0.18 mg/l on day 2, there was a secondary increase in cystatin C concentrations to 2.69+/-0.35 mg/l on day 10. Creatinine concentrations continued to decline until day 9 reaching 80.5+/-13.1 micromol/l. Day-to-day variation at steady-state was comparable. In the course of 9 acute rejection episodes, both parameters rose in parallel, the increase in creatinine concentration being much greater.
Conclusion:
Cystatin C was an early indicator of allograft function following successful RTX in children. It did not prove superior to creatinine for the recognition of acute allograft dysfunction, however.
Related Concept Videos
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Serum Studies: Renal Function Tests
Acute Kidney Injury III: Clinical Manifestations

